U.S. equities fell Thursday, giving back early gains that
followed the European Central Bank pumping more stimulus in the
regional economy and a larger-than-expected decline in the U.S.
trade gap for last month. Both the S&P 500 and Dow Jones
Industrial Average again touched new record highs before turning
lower today as investors likely squared positions ahead of the
Labor Department Friday reports on August hiring. A stronger U.S.
dollar undermined crude oil and gold futures, dragging the shares
of energy and mining companies lower.
European markets finished higher and U.S. equities also rallied
early in today's trading after the European Central Bank surprised
investors with a larger-than-expected cut in interest rates to just
0.05% as well as announcing plans for 40 billion euros in
quantitative easing in a bid to shore up a flagging regional
The US trade deficit shrank for the third straight month in
July, Commerce Department data showed Thursday, coming in at $40.5
billion, down from a $40.8 billion deficit in June.
Commodities were mostly lower. Crude oil for October delivery
settled $1.09 lower at $94.95 per barrel while October natural gas
fell 3 cents to $3.82 per 1 million BTU. December gold declined
$4.00 to $1,266.10 per ounce while December silver slipped 7 cents
to $19.13 per ounce. December copper rose 2 cents to settle at
$3.15 per pound.
Here's where U.S. stocks stood at the end-of-day:
Dow Jones Industrial Average down 8.70 (-0.05%) to 17,069.58
S&P 500 down 3.07 (-0.15%) to 1,997.65
Nasdaq Composite Index down 10.28 (-0.22%) to 4,562.29
Hang Seng Index down 0.08%
Shanghai China Composite Index up 0.80%
FTSE 100 Index up 0.06%
(+) BOLT, Accepts $171 million buyout offer by Teledyne
), which pay $22 per share in cash for the underwater
(+) MITK, Settles all pending litigation with USAA, which agreed
to drop accusations of misappropriating trade secrets and breach of
contract. USAA keeps its license to use MITK's Quick Strokes, Quick
FX Pro and Image Score software.
(+) STXS, Receives 510(k) clearance from FDA to market its
Vdrive robotic navigation system with V-Loop variable loop catheter
manipulator in the U.S. Agency approval follows completion of
120-patient, multi-center clinical study.
(-) MTRX, Reports Q4 net income of $0.28 per share, missing
analyst estimates by $0.08. Revenue rises 46.2% year over year to
$344.36 mln, trailing Street view by around $9.58 mln. Projected
FY15 EPS lags consensus by at least $0.19 per share.
(-) KMDA, Still seeking EU authorization for drug candidate to
treat Alpha-1 Antitrypsin deficiency despite failing to produce
statistically significant difference from placebo in primary and
secondary endpoints during Phase II/III testing.
(-) SCVL, Q2 net income declines to $2.6 mln, or $0.13 per
share, from a $5.8 mln profit last year, missing consensus by $0.02
per share. Revenue rises 2.6% to $222.1 mln, trailing expectations
by $2.9 mln. Q3 EPS forecasts lags Street view by at least $0.08